Pharmaceutical Management: Our Impact

Could people become immune?A paper by Dr. Malcolm Bryant of Management Sciences for Health was presented at the American Public Health Association Conference in San Francisco last November. The topic of this provocative presentation was whether widespread resistance to antiretroviral agents is inevitable in Africa.Antiretroviral treatments provide hope to people infected with HIV/AIDS in Africa and around the world. However, this treatment requires an absolutely accurate prescription coupled with an adherence by the patient to a prescribed regimen.

During 2002 alone, 3.1 million people died of AIDS and another 5 million were newly infected. Young people ages 15-24 account for 42 percent of new HIV infections and represent almost one-third of people living with HIV/AIDS worldwide.

Grant to help countries develop drug and vaccine programs to be used globally BOSTON, MA — Management Sciences for Health (MSH) will use a $29.9 million grant from the Bill & Melinda Gates Foundation to improve the drug supply systems of developing countries and create new public-private models that will promote sustainable, equitable access to priority drugs and vaccines throughout the world.

GEORGETOWN, GUYANA  — Guyana, one of the 15 priority countries identified by President George W. Bush for AIDS relief, recently received US$110,000 in pediatric antiretroviral (ARV) drugs from the US Government. US Ambassador Roland Bullen transferred the life-prolonging drugs to Minister of Health Dr. Leslie Ramsammy during an official ceremony in Guyana.

Pages